Global and regional burden of measles and vaccine coverage among children under 5 years, 1990−2023: a Global Burden of Disease Study
Nature Medicine
بشير الدين اصدق سيد محمد
— Clinical Pharmacy
All Scopus documents
292Lancet Infectious Diseases
Lancet
Lancet Respiratory Medicine
Lancet Infectious Diseases
Food Control
Lancet Infectious Diseases
Food Chemistry
Comprehensive Reviews in Food Science and Food Safety
Advances in heavy metal removal from fruit juices: implications for food safety and quality control
Critical Reviews in Food Science and Nutrition
Lancet Child and Adolescent Health
Lancet Public Health
International Journal of Analytical Chemistry
Nature Medicine
International Journal of Analytical Chemistry · vol. 2026 (1) · 4376722-4376722
Dasatinib, a therapy for chronic myeloid leukemia, suffers from poor bioavailability. Self‐microemulsifying drug delivery systems (SMEDDSs) are used to improve its dissolution. This study aimed to develop and validate a novel reverse‐phase high‐performance liquid chromatography (RP‐HPLC) method for quantifying dasatinib in SMEDDS formulations. The RP‐HPLC method utilized a mobile phase of methanol and 0.1% trifluoroacetic acid (55:45, v/v) and identified a peak wavelength for dasatinib at 324 nm. SMEDDS formulations comprised Capryol 90, Transcutol HP, and Tween 40. The method was validated according to ICH guidelines, demonstrating excellent linearity ( R 2 = 0.9993), accuracy (recovery between 98% and 101%), and precision (relative standard deviation of 0.73%). It also showed stability and reliability with limits of detection and quantification of 0.17 and 0.50 µg/mL, respectively. This RP‐HPLC method meets all validation criteria and provides a robust, cost‐effective tool for analyzing dasatinib in SMEDDS formulations.
Frontiers in Public Health · vol. 14 · 1768449-1768449
Background: Obesity remains a major global health challenge and a significant contributor to chronic diseases. This study aimed to assess knowledge, attitudes, and practices (KAP) related to obesity and to identify sociodemographic and clinical factors influencing these domains among individuals with obesity. Methods: A cross-sectional survey was conducted using a convenience, non-probability sampling method among individuals with obesity recruited from hospitals, health clinics, and community settings. Obesity-related knowledge, attitudes, and practices were assessed, and multinomial regression analyses were performed to identify factors associated with KAP outcomes. Results: A total of 419 participants were included, with a nearly equal gender distribution and a predominantly young adult population, most of whom had university-level education. Overall, 45.3% demonstrated satisfactory knowledge, 42.2% exhibited positive attitudes, and 43.0% reported effective practices regarding obesity management. Increasing age (OR = 1.361, 95% CI: 1.134-1.635) and higher education (OR = 2.417, 95% CI: 1.575-3.710) were significantly associated with satisfactory knowledge. Male participants were more likely to exhibit negative attitudes than females (OR = 1.909, 95% CI: 1.141-3.195), while individuals diagnosed with obesity were less likely to report non-satisfactory attitudes (OR = 0.495, 95% CI: 0.290-0.845). Effective practices were associated with age (OR = 1.296, 95% CI: 1.076-1.562) and obesity diagnosis (OR = 0.475, 95% CI: 0.278-0.811). Perceptions of nutritional value significantly influenced both knowledge (OR = 0.741, 95% CI: 0.571-0.961) and practices (OR = 0.384, 95% CI: 0.288-0.512). Conclusion: The findings highlight the role of key sociodemographic and clinical factors-particularly age, education, and obesity diagnosis-in shaping obesity-related knowledge, attitudes, and practices. Targeted educational and behavioral interventions, especially among younger individuals and males, along with improved awareness of nutritional value, may enhance obesity management outcomes.
Frontiers in Aging Neuroscience · vol. 18 · 1742343-1742343
Background: Sleep is a fundamental biological process essential for maintaining mental, emotional, and physical health. Chronic sleep deprivation (SD), particularly in aging, is associated with oxidative stress, neuroinflammation, apoptosis, and cognitive and behavioral impairments. Oxytocin, a hypothalamic neuropeptide with reported antioxidant and anti-inflammatory properties, may modulate stress-related pathways; however, its role in mitigating SD-induced brain alterations remains unclear. This study investigated whether peripheral oxytocin administration influences brain and behavioral changes induced by chronic SD in aged rats. Methods: Male Sprague Dawley rats aged 20-24 months were divided into four groups: control, oxytocin-treated, SD, and SD with oxytocin treatment. Chronic SD was induced using a modified multiple platform method. Behavioral assessments were conducted to evaluate locomotor and exploratory activity. Serum cortisol was measured as a systemic stress marker, while brain tissues were analyzed for oxidative stress and inflammatory markers. Gene expression of Psen1 and Htr2a, oxytocin receptor protein levels, and histopathological changes, including gliosis and apoptosis, were also evaluated. Results: Chronic SD resulted in significant impairments in locomotor and exploratory behaviors, elevated serum cortisol levels, and increased oxidative stress and inflammatory markers. SD also altered the expression of Psen1 and Htr2a, reduced oxytocin receptor protein levels, and was associated with histological evidence of gliosis and apoptosis in brain tissues. Peripheral oxytocin administration attenuated many of these SD-induced alterations. However, because oxytocin was administered peripherally and central oxytocin levels or receptor engagement were not directly assessed, the findings cannot be interpreted as definitive evidence of direct central neuroprotection. Conclusion: The results suggest that oxytocin modulates stress responses, oxidative balance, and inflammatory pathways in aged rats subjected to chronic sleep deprivation. Although the precise central mechanisms remain unresolved, these findings support a potential role for oxytocin in mitigating SD-associated pathophysiological changes in aging and warrant further mechanistic studies to clarify its neuroprotective potential.
Nutrire · vol. 51 (1)
Abstract The present study examined the modulatory effects of Ocimum gratissimum leaf flavonoid-rich extracts on the Nrf-2 and HO-1 pathways in the livers of streptozotocin-induced diabetic rats. The animals were divided into five groups ( n = 8). These included a normal control, a diabetic control, diabetic rats administered low (LDOGFL) or high (HDOGFL) doses of Ocimum gratissimum leaf flavonoid-rich extracts at 150 and 300 mg/kg, respectively, and diabetic rats administered 200 mg/kg metformin. The animals were sacrificed on the 22nd day of the study, the liver was excised, and different biochemical parameters were evaluated. At the end of this study, diabetic rats administered LDOGFL and HDOGFL presented significant ( p < 0.05) decreases in fragmented DNA, protein carbonyl and lipid peroxidation levels, as well as glucose-6-phosphatase, and fructose 1,6 bisphosphatase activities. However, there was a significant ( p < 0.05) increase in the levels of antioxidant biomarkers; phosphatase and transaminase activities; GLUT 2 and glycogen levels; glycogen synthase and phosphorylase; hexokinase, pyruvate kinase and glucose-6-phosphate dehydrogenase activities; and serum albumin and insulin in diabetic rats treated with extracts. Furthermore, there was a substantial increase in the relative gene expression of Nrf2 and HO-1, especially in diabetic rats administered LDOGFL. Hence, these findings suggest that these extracts might be helpful in managing hepatopathy in patients with diabetes mellitus.
Advanced Health Science and Technology Journal · vol. 2 (1) · 1-1
Journal of Disability Research · vol. 5 (3)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. Public knowledge and awareness of AD play an important role in early recognition, risk reduction, and support for affected individuals. This study aimed to assess AD-related knowledge among adults in Riyadh, Saudi Arabia, using the validated Alzheimer’s Disease Knowledge Scale (ADKS), and to identify sociodemographic factors associated with knowledge levels. A community-based cross-sectional study was conducted among 1282 adults recruited from public locations across Riyadh using a stratified convenience sampling approach. Data were collected through face-to-face interviews using a structured questionnaire and the 30-item ADKS. The scale assessed knowledge across seven domains: life impact, risk factors, disease course, assessment and diagnosis, caregiving, treatment and management, and symptoms. Descriptive statistics, independent-samples t -tests, one-way analysis of variance, Tukey’s post hoc analysis, and multiple linear regression were performed using SPSS version 25 (IBM Corp., Armonk, NY, USA). The mean total ADKS score was 17.09 ± 3.00 out of 30, corresponding to 56.95% correct responses, indicating moderate knowledge of AD among participants. The highest domain-specific knowledge scores were observed in assessment and diagnosis (66.25%) and treatment and management (66.25%), while the lowest scores were observed in caregiving (46.2%). Mean ADKS scores differed significantly by age group ( P = 0.037), gender ( P < 0.001), educational level ( P = 0.007), marital status ( P = 0.007), and family history of AD ( P < 0.001). Multiple linear regression analysis showed that female gender ( B = 0.952, P < 0.001), higher educational level ( B = 0.177, P = 0.012), increasing age category ( B = 0.229, P = 0.012), and having a family history of AD ( B = 0.800, P < 0.001) were independently associated with higher ADKS scores. Adults in Riyadh demonstrated moderate knowledge regarding AD, with notable knowledge gaps particularly related to caregiving and other disease-related domains. Sociodemographic characteristics, especially gender, education, age, and family exposure to AD, were associated with knowledge levels. Targeted community-based educational interventions addressing identified knowledge gaps are warranted to improve AD awareness and promote early recognition and supportive care in Saudi Arabia.
Biogerontology · vol. 26 (2) · 79-79
Journal of Infection and Public Health · vol. 18 (6) · 102763-102763
Leprosy and tuberculosis caused by Mycobacterium leprae and Mycobacterium tuberculosis, respectively, are chronic infections with significant public health implications. While leprosy affects the skin and peripheral nerves and tuberculosis primarily targets the lungs, both diseases involve systemic immune responses. This study integrates transcriptomic analysis cheminformatics and molecular dynamics simulations to identify molecular mechanisms and potential therapeutic targets. Transcriptomic datasets were analyzed to identify dysregulated genes and pathways. Pathway enrichment tissue-specific and bulk RNA-seq expression analyses provided biological context. System biology networks revealed regulatory hub genes and molecular docking studies evaluated CHEMBL compounds as potential therapeutics. Molecular dynamics (MD) simulations assessed the stability of top ligand-protein complexes through RMSD RMSF and MM-GBSA free energy calculations. Gene expression analysis identified 13 core dysregulated genes, including HSP90AA1 MAPK8IP3 and ZMPSTE24. Tissue-specific expression localized pivotal genes to lung tissues and immune cells with HSP90AA1 highly expressed in alveolar macrophages and epithelial cells. HSP90AA1 gene emerged as a central hub gene with 96 interactions involved in stress response pathways. Docking studies identified CHEMBL3653862 and CHEMBL3653884 with strong binding affinities (-10.16 to −12.69 kcal/mol) interacting with Asp93 and Tyr139. MD simulations confirmed binding stability with RMSD fluctuations within 2.1–3.5 Å and MM-GBSA energy values supporting ligand-protein stability. This study identifies HSP90AA1 as a potential drug target in leprosy and tuberculosis. Findings support host-directed therapy approaches and highlight the importance of computational modeling in accelerating drug discovery. The study provides a foundation for future experimental validation, including in vitro and in vivo testing to advance drug repurposing strategies for these chronic infections. • Identified 13 shared dysregulated genes between tuberculosis and leprosy. • Uncovered critical pathways and protein-protein interactions using network medicine. • Highlighted roles of genes in immune-related cells through tissue-specific and single-cell gene expression analyses. • Conducted drug repurposing analysis, identifying CHEMBL compounds with strong binding affinities for key targets. • Deliver a comprehensive understanding of disease mechanisms and therapeutic opportunities.
Starch - Stärke · vol. 77 (9)
ABSTRACT The growing environmental concerns associated with petrochemical‐based plastics, including their persistence, contribution to climate change, and adverse effects on ecosystems and human health, have accelerated the search for sustainable alternatives. Starch‐based bioplastics have emerged as a promising solution due to their biodegradability, renewability, and compatibility with existing food packaging technologies. This review comprehensively examines production mechanisms of starch‐based bioplastics, focusing on their formulation, structural modifications, and industrial applications. The role of plasticizers in improving flexibility and reducing brittleness is discussed. Their natural decomposition into environmentally benign byproducts supports a circular economy and aligns with global sustainability goals. However, the downside of using bioplastic is that the raw material used for its fabrication is also used for sustenance, and so a trade‐off between growing feedstock crops and food production is inevitable. The higher manufacturing costs of bioplastics as compared to conventional plastics are also a limiting factor. Hence, bioplastics do not completely serve as a long‐term panacea for problems associated with plastic pollution. This review therefore attempts to (i) enumerate the benefits of starch in food packaging, (ii) delineate the physical and chemical treatments that enhance hydrophobicity, mechanical strength, and thermal stability, (iii) suggest the proper disposal procedures to ward off health issues and to conserve the environment, and (iv) advocate the implementation of stringent recycling measures and emphasize on the policies and legislation for green transition. Future research should focus on optimizing polymer blends, reinforcing compatibility with synthetic and natural polymers, and advancing manufacturing techniques to enable widespread adoption in food packaging applications.
Food Chemistry · vol. 499 · 147325-147325
Food Control · vol. 181 · 111716-111716